Imperial Laboratories

Evartia is a genetic test that screens for genetic changes associated with inherited metabolic diseases in 223 genes. Symptoms of inherited metabolic diseases can manifest shortly after birth or at infancy, childhood, adolescence or adulthood.

With Evartia, early detection has a higher potential to reduce symptoms or minimize their severity, improving the quality of life of the person with the metabolic disease.

For more info about Evartia and how it can help you, visit: https://nipd.com/products/postnatal/evartia/

Results from Whole Exome Sequencing (WES) analysis could guide you to reach a diagnosis sooner, avoiding extensive, costly and lengthy serial testing.

NIPD Genetics WES analysis is an advanced genetic test that looks at the genetic information of approximately 20,000 genes in a single test.
Discuss with your doctor if WES analysis is right for you.

👉For more info visit: https://nipd.com/products/wes/

When detected early, the conditions tested in Oreana Neonatal Screening can be manageable or treatable given how therapies and clinical management can prevent serious, life-long consequences including developmental delay and premature death, benefiting the prognosis and the quality of life of the affected child.

👉Further info about the expanded Oreana Neonatal Screening can be found here: https://nipd.com/products/neonatal/oreana-patients/

When it comes to your baby’s health, you don’t want to be surprised

VERAgene is the only comprehensive NIPT test that can simultaneously screen for common aneuploidies, selected clinically significant microdeletions and a panel of 100 single gene (monogenic) diseases, like β-thalassemia, cystic fibrosis and phenylketonuria, as early as the 10th week of pregnancy.

Talk to your doctor to learn more about whether VERAgene comprehensive NIPT is right for you.

For more info visit:
https://nipd.com/products/prenatal/veragene-patients/

July is Sarcoma Awareness month!

Sarcomas are uncommon cancers that can occur in various locations of the body. Early detection is important to increase the chances of successful treatment.
Li-Fraumeni syndrome (LFS) that is included in the PreSENTIA hereditary cancer test panels, is an inherited familial predisposition cancer syndrome that is associated with an increased risk of sarcomas, among other cancers.

For more information, please visit:
https://nipd.com/products/oncology/presentia/

When can NeoThetis liquid biopsy test be performed?

NeoThetis can be performed at diagnosis for therapy selection, or during disease progression, when the patient has acquired resistance to previous treatment, for therapy re-evaluation.

For more information about Neo Thetis:
https://nipd.com/products/oncology/neothetis/

NIPD Genetics’ innovative genetic testing services in Reproductive Health helps clinicians provide their patients with robust, reliable and time-sensitive solutions at the preconception, preimplantation and prenatal phases of their reproductive journey.

To learn more about our comprehensive reproductive health portfolio of genetic testing services and laboratory solutions visit: https://nipd.com/

It’s International PKU Awareness Day!

Phenylketonuria (PKU) is an inherited, autosomal recessive condition. Treatment of PKU consists of maintaining phenylalanine levels within normal range through a controlled, specialized diet that must be followed throughout the patient’s life, otherwise symptoms can appear.

VERAgene comprehensive , offered by NIPD Genetics a Medicover Company, can detect PKU, along with 99 other monogenic diseases, aneuploidies and microdeletions from the 10th week of pregnancy.

To learn more about PKU, read our blog post at www.nipd.com/blog

It's Global Rare Chromosome Disorder Awareness Week!

A week to educate and shine a light on the individuals and families affected by rare chromosome disorders and celebrate all the unique children and adults.

Learn more about chromosomes and rare disorders at https://nipd.com/articles/blog/

June: Men's Health Awareness Month🩺

This month is all about raising awareness of preventable health problems and encouraging all men and boys to seek early detection, regular medical advice and early treatment for diseases.

Head over to our blog for more info about Men's Health: https://nipd.com/articles/blog/movember-focusing-on-social-awareness-about-mens-health/

Today is

The otherwise known as 4p- syndrome is a rare genetic disorder caused by a missing piece of genetic material on chromosome 4, which usually results in characteristic facial features, seizures, and various physical disabilities.

Children with 4p- syndrome are usually born with low birth weight and develop slowly, both cognitively and physically, compared to their same-age peers, and experience medical complications while maintaining strong social skills.

Wolf-Hirschhorn Syndrome is screened by both our prenatal tests, VERACITY NIPT and VERAgene Comprehensive NIPT, for early detection.

Learn more about VERACITY and VERAgene NIPTs at www.nipd.com

With VERACITY new generation NIPT you can get valuable insights into your baby’s health as early as 10 weeks into your pregnancy. VERACITY is validated in three multi-center studies using thousands of samples and it is used by health professionals around the world. Ask your doctor about VERACITY today. You can also visit nipd.com to learn more about all the conditions screened by VERACITY.

NOW AVAILABLE IN PAKISTAN
For more details contact us:

NOW AVAILABLE IN PAKISTAN
For more details contact us:

The number of detected skin cancer cases is growing with worrying rates. Over the past three decades, more people have been diagnosed with a form of skin cancer than all other cancers together. During Skin Cancer Awareness Month, we encourage screening for early detection, as it is vital towards a better prognosis.

PreSENTIA offers the Skin (XP associated) Cancer Panel that screens for hereditary cancer disposition, while ForeSENTIA offers the Melanoma Panel for accurate tumor profile of the specific cancer.

For more information on Melanoma/Skin Cancer, you can read our blog: https://nipd.com/articles/blog/melanoma-skin-cancer-awareness-month-may-2021/

May is . Time to shed light on this inherited genetic disease that causes severe damage mostly to the lungs, but also to other parts of the body over time. Since there is no definite cure for Cystic Fibrosis, early screening right after birth or even before conceiving is highly recommended.

Oreana neonatal screening and Adventia carrier screening both test for the genes that may potentially cause Cystic Fibrosis.

For more information on Cystic Fibrosis, you can read our blog:
https://nipd.com/articles/blog/cystic-fibrosis/

Today is

The otherwise known as 4p- syndrome is a rare genetic disorder caused by a missing piece of genetic material on chromosome 4, which usually results in characteristic facial features, seizures, and various physical disabilities.

Children with 4p- syndrome are usually born with low birth weight and develop slowly, both cognitively and physically, compared to their same-age peers, and experience medical complications while maintaining strong social skills.

Wolf-Hirschhorn Syndrome is screened by both our prenatal tests, VERACITY NIPT and VERAgene Comprehensive NIPT, for early detection.

Learn more about VERACITY and VERAgene NIPTs at www.nipd.com

With Oreana, early detection of life-altering disorders can benefit the infant’s health and quality of life. Oreana is non-invasive and painless for the infant, and it tests for disease-causing genetic mutations that cause serious health problems.
For the full list of conditions screened by Oreana, please visit www.nipd.com/oreana

NOW AVAILABLE IN PAKISTAN
For more details contact us:

Anyone can be a carrier of certain genetic mutations (changes in the DNA) that may lead to genetic diseases. Knowing your carrier status can provide information regarding your reproductive options and minimize the risk of transmitting a genetic disease to your children.

For further information on the conditions screened by Adventia, please visit www.nipd.com/adventia

We are now taking queries about genetic testing in Pakistan

With VERACITY new generation NIPT you can get valuable insights into your baby’s health as early as 10 weeks into your pregnancy. VERACITY is validated in three multi-center studies using thousands of samples and it is used by health professionals around the world. Ask your doctor about VERACITY today. You can also visit nipd.com to learn more about all the conditions screened by VERACITY.

NOW AVAILABLE IN PAKISTAN
For more details contact us:

Rodinia™ for Doctors: Male & Female Infertility Testing Panel

https://nipd.com/products/reproductive/rodinia-doctors/

Rodinia™ for Doctors: Male & Female Infertility Testing Panel An infertility genetic test for couples with fertility problems that offers a female and a male infertility panel, and a haemophilia and thrombosis panel.

VERACITY Non Invasive Prenatal Test (For Patients)

https://youtu.be/1w-lg3cpRO8
NOW AVAILABLE IN PAKISTAN
For more details contact us:

VERACITY Non Invasive Prenatal Test (For Patients) VERACITY is the most accurate non-invasive prenatal test to safely detect genetic diseases such as trisomies, s*x chromosome aneuploidies, and microdeletions...

March 21 is Trisomy 21 – Down syndrome Awareness Day
Trisomy 21 is a genetic condition that arises when a person has 3 copies of chromosome 21 instead of the typical pair, making the total chromosomal count 47 instead of 46.
Prenatal screening of trisomy 21, can be performed as early as the 10th week of pregnancy via VERACITY or VERAgene NIPTs.
For further information on trisomy 21, head to our blog post:🔗 https://nipd.com/articles/blog/trisomy-21-down-syndrome/

Trisomy 18 is the second most common and second most severe trisomy, Globally, the condition occurs in approximately 1 in 5,000 live births. The prevalence is greater, estimated to be around 1 in 2,500. Prenatal detection of trisomy 18 can be achieved through 1st and 2nd-trimester screening. Thus, NIPT can reduce the number of unnecessary invasive procedures, and give parents invaluable time to think and research their options regarding clinical management and care.
NOW AVAILABLE IN PAKISTAN
For more details contact us:

Rodinia™ | Infertility Genetic Testing

https://fb.watch/bMYuRt4t40/
Rodinia is a new genetic test that screens for mutations associated with infertility in individuals and couples who have difficulty conceiving and maintaining a pregnancy. Rodinia identifies the underlying genetic cause of infertility and provides deep insight into reproductive potential and health.
To learn more about Rodinia and how it will benefit your reproductive health, visit www.nipd.com/rodinia

Rodinia™ | Infertility Genetic Testing Rodinia screens for genetic changes associated with infertility. Rodinia can enable accurate prognosis and help the couple achieve pregnancy.

March 13 is Trisomy 13 – Patau syndrome Awareness Day.

Trisomy 13 is a genetic condition that arises when mistakes occur during cell division and fertilization, when the egg or the s***m carry an additional copy of chromosome 13 and pass it on to the embryo.

Prenatal screening of trisomy 13, can be performed as early as the 10th week of pregnancy via VERACITY or VERAgene NIPTs. For further information on trisomy 13, head to our blog post.
https://nipd.com/articles/blog/trisomy-13-patau-syndrome/

VERACITY is a new generation non-invasive prenatal test that simultaneously checks for autosomal and s*x chromosomes aneuploidies, as well as microdeletions, in the fetus before birth. VERACITY is safely performed using a simple blood draw from the mother, and is applicable for all pregnant women.
For more information visit nipd.com/veracity

VERACITY is an accurate, safe and simple non-invasive prenatal test for women who are at least 10 weeks pregnant and would like reassurance about the health of their baby. Talk to your doctor about VERACITY.

World Kidney Day🔴🔵🟡

In light of , we turn our focus to the importance of genetic testing for hereditary renal (kidney) cancer, which accounts for 5-8% of all renal cancers.

The Hereditary Renal cancer panel, offered by NIPD Genetics, tests for genetic mutations (changes in the DNA) that can raise someone's risk of developing hereditary renal cancer in the future. Identifying one's risk can empower healthcare providers and patients to take informed decisions about clinical care and management.

Learn more here 🔗www.nipd.com/presentia

Up to 25% of ovarian cancer cases can result from inherited changes, known as germline mutations, which run in families and increase the chances of developing hereditary .

The PreSENTIA hereditary gynecological cancer panel tests for numerous germline mutations that could be responsible for developing ovarian cancer, among other gynecological cancers, in the future. Identifying germline mutations can help doctors towards an informed medical approach, which can include routine screening to detect cancer early and identify the patients’ family members who carry the same genes.

Learn more here: www.nipd.com/presentia

A safe and non-invasive prenatal test.

Safe and non-invasive prenatal test.

A safe and non-invasive prenatal test.

You can send a message directly to Imperial Laboratories.

You can send a message directly to Imperial Laboratories.

VERAgene Comprehensive NIPT

https://youtu.be/pdW3qzgr_e8
Source: Nipd.com

VERAgene Comprehensive NIPT VERAgene is the first comprehensive non-invasive prenatal test (NIPT) that can simultaneously screen for aneuploidies, microdeletions and point mutations. Th...

NIPD and IL collaboration brings the most advanced nipt testing (in Pakistan)